Gene · 7516
Papers1,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 1,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis. | Breast Cancer Res Treat | 2020 | 32488392 | PubTator, text mining | PubMed |
| A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer. | Cancer Epidemiol Biomarkers Prev | 2020 | 32467344 | PubTator, text mining | PubMed |
| The FANC/BRCA Pathway Releases Replication Blockades by Eliminating DNA Interstrand Cross-Links. | Genes (Basel) | 2020 | 32466131 | PubTator, text mining | PubMed |
| Genetic Variations of RAD51 and XRCC2 Genes Increase the Risk of Colorectal Cancer in Bangladeshi Population. | Asian Pac J Cancer Prev | 2020 | 32458654 | PubTator, text mining | PubMed |
| Human Brain Organoids to Decode Mechanisms of Microcephaly. | Front Cell Neurosci | 2020 | 32457578 | PubTator, text mining | PubMed |
| Breast Cancer Derived Extracellular Vesicles in Bone Metastasis Induction and Their Clinical Implications as Biomarkers. | Int J Mol Sci | 2020 | 32443642 | PubTator, text mining | PubMed |
| High Content Imaging of Barrett's-Associated High-Grade Dysplasia Cells After siRNA Library Screening Reveals Acid-Responsive Regulators of Cellular Transitions. | Cell Mol Gastroenterol Hepatol | 2020 | 32416156 | PubTator, text mining | PubMed |
Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast. | Arch Toxicol | 2020 | 32399610 | PubTator, text mining | PubMed |
| Analysis of the association between the XRCC2 rs3218536 polymorphism and ovarian cancer risk. | Arch Med Sci | 2020 | 32399118 | PubTator, text mining | PubMed |
| Identification of a Novel Eight-lncRNA Prognostic Signature for HBV-HCC and Analysis of Their Functions Based on Coexpression and ceRNA Networks. | Biomed Res Int | 2020 | 32382578 | PubTator, text mining | PubMed |
| PEX5, a novel target of microRNA-31-5p, increases radioresistance in hepatocellular carcinoma by activating Wnt/β-catenin signaling and homologous recombination. | Theranostics | 2020 | 32373215 | PubTator, text mining | PubMed |
| Drug Targeting of Genomic Instability in Multiple Myeloma. | Front Genet | 2020 | 32373151 | PubTator, text mining | PubMed |
| Development and validation of next generation sequencing based 35-gene hereditary cancer panel. | Hered Cancer Clin Pract | 2020 | 32368312 | PubTator, text mining | PubMed |
| Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer. | Geburtshilfe Frauenheilkd | 2020 | 32322110 | PubTator, text mining | PubMed |
| Evaluation of pathogenetic mutations in breast cancer predisposition genes in population-based studies conducted among Chinese women. | Breast Cancer Res Treat | 2020 | 32318955 | PubTator, text mining | PubMed |
| Modification of PARP4, XRCC3, and RAD51 Gene Polymorphisms on the Relation between Bisphenol A Exposure and Liver Abnormality. | Int J Environ Res Public Health | 2020 | 32316696 | PubTator, text mining | PubMed |
| Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer. | Cancer Treat Rev | 2020 | 32311593 | PubTator, text mining | PubMed |
| Mammalian RAD51 paralogs protect nascent DNA at stalled forks and mediate replication restart. | Nucleic Acids Res | 2020 | 32301983 | PubTator, text mining | PubMed |
| Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets. | Front Cell Dev Biol | 2020 | 32300589 | PubTator, text mining | PubMed |
| A reference map of the human binary protein interactome. | Nature | 2020 | 32296183 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7516/papers?page=36